We enrolled 479 patients with subarachnoid hemorrhage in a multicenter, randomized, double-blind, placebo-controlled trial to determine whether treatment with the antifibrinolytic agent tranexamic acid improves outcome by preventing rebleeding. At three months there was no statistical difference between the outcomes in the tranexamic acid group and the control group. Of the 173 patients who died, 84 had received tranexamic acid and 89 placebo (95 per cent confidence interval for the difference in mortality rate, -6 to 11 per cent). Similarly, when analysis was restricted to patients with an angiographically demonstrated aneurysm, there was no significant difference between the groups. This absence of effect was not due to a lack of antifibrinolytic action, since the rate of rebleeding was reduced from 24 per cent in the control group to 9 per cent in the tranexamic acid-treated group (chi-square = 18.07, P less than 0.001), but resulted from a concurrent increase in the incidence of ischemic complications (15 per cent in the control group and 24 per cent in the tranexamic acid group; chi-square = 8.07, P less than 0.01). We conclude that until some method can be found to minimize ischemic complications, tranexamic acid is of no benefit in patients with subarachnoid hemorrhage.
This article has been cited by other articles:
Mahdy, A. M., Webster, N. R.
(2004). Perioperative systemic haemostatic agents. Br J Anaesth
93: 842-858
[Abstract][Full Text]
Ruigrok, Y M, Rinkel, G J E, Wijmenga, C, van Gijn, J
(2004). Anticipation and phenotype in familial intracranial aneurysms. J. Neurol. Neurosurg. Psychiatry
75: 1436-1442
[Abstract][Full Text]
Dorhout Mees, S. M., Rinkel, G. J.E., Hop, J. W., Algra, A., van Gijn, J.
(2003). Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review. Stroke
34: 2285-2289
[Abstract][Full Text]
Mayer, S. A.
(2003). Ultra-Early Hemostatic Therapy for Intracerebral Hemorrhage. Stroke
34: 224-229
[Abstract][Full Text]
Kirkpatrick, P J
(2002). SUBARACHNOID HAEMORRHAGE AND INTRACRANIAL ANEURYSMS: WHAT NEUROLOGISTS NEED TO KNOW. J. Neurol. Neurosurg. Psychiatry
73: i28-33
[Full Text]
Soustiel, J. F., Levy, E., Bibi, R., Lukaschuk, S., Manor, D.
(2001). Hemodynamic Consequences of Cerebral Vasospasm on Perforating Arteries : A Phantom Model Study. Stroke
32: 629-635
[Abstract][Full Text]
van Gijn, J., Rinkel, G. J. E.
(2001). Subarachnoid haemorrhage: diagnosis, causes and management. Brain
124: 249-278
[Abstract][Full Text]
Roos, Y.
(2000). Antifibrinolytic treatment in subarachnoid hemorrhage: A randomized placebo-controlled trial. Neurology
54: 77-77
[Abstract][Full Text]
Bennett-Guerrero, E., Spillane, W. F., White, W. D., Muhlbaier, L. H., Gall, S. A. Jr, Smith, P. K., Newman, M. F.
(1999). {{varepsilon}}-aminocaproic acid administration and stroke following coronary artery bypass graft surgery. Ann. Thorac. Surg.
67: 1283-1287
[Abstract][Full Text]
ROOS, Y B W E M, VERMEULEN, M, RINKEL, G J E, ALGRA, A, VAN GIJN, J, ALGRA, A
(1998). Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry
65: 942-943
[Full Text]
Mannucci, P. M.
(1998). Hemostatic Drugs. NEJM
339: 245-253
[Full Text]
McCormick, P A, Ooi, H, Crosbie, O
(1998). Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut
42: 750-752
[Abstract][Full Text]
Vermeij, F. H, Hasan, D., Bijvoet, H. W. C., Avezaat, C. J. J.
(1998). Impact of Medical Treatment on the Outcome of Patients After Aneurysmal Subarachnoid Hemorrhage. Stroke
29: 924-930
[Abstract][Full Text]
Roos, Y B W E M, Beenen, L F M, Groen, R J M, Albrecht, K W, Vermeulen, M
(1997). Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J. Neurol. Neurosurg. Psychiatry
63: 490-493
[Abstract][Full Text]
Bromberg, J.E.C., Rinkel, G.J.E., Algra, A., Limburg, M., van Gijn, J.
(1995). Outcome in Familial Subarachnoid Hemorrhage. Stroke
26: 961-963
[Abstract][Full Text]
Grotta, J. C
(1991). Prevention and management of stroke. Vasc Med
2: 3-17
McNutt, R. A., Pauker, S. G.
(1987). Competing Rates of Risk in a Patient with Subarachnoid Hemorrhage and Myocardial Infarction: It's Now or Never. Med Decis Making
7: 250-259
Solomon, R. A., Fink, M. E.
(1987). Current Strategies for the Management of Aneurysmal Subarachnoid Hemorrhage. Arch Neurol
44: 769-774
[Abstract]
Thie, A., Spitzer, K., Kunze, K.
(1987). Spontaneous Subarachnoid Hemorrhage: Assessment of Prognosis and Initial Management in the Intensive Care Unit. J Intensive Care Med
2: 103-115
[Abstract]
Adams, H. P. Jr
(1987). Antifibrinolytics in Aneurysmal Subarachnoid Hemorrhage: Do They Have a Role? Maybe. Arch Neurol
44: 114-115
[Abstract]
Weir, B.
(1987). Antifibrinolytics in Subarachnoid Hemorrhage: Do They Have a Role? No. Arch Neurol
44: 116-118
[Abstract]
Previous
